Viking Therapeutics
VKTX
VKTX
114 hedge funds and large institutions have $76.5M invested in Viking Therapeutics in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 43 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
-26
Holders Change %
-18.57%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
25
Reduced
43
Closed
42
Calls
$1.49M
Puts
$311K
Net Calls
+$1.18M
Net Calls Change
+$754K
Top Buyers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
$7.64M |
| 2 |
LCM
Laurion Capital Management
New York
|
$3.83M |
| 3 |
E
Ergoteles
New York
|
$955K |
| 4 |
Morgan Stanley
New York
|
$1.91M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
$2.41M |
Top Sellers
| 1 |
BlackRock
New York
|
$4.12M |
| 2 |
State Street
Boston,
Massachusetts
|
$754K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
$1.98M |
| 4 |
Northern Trust
Chicago,
Illinois
|
$366K |
| 5 |
Citadel Advisors
Miami,
Florida
|
$347K |
